Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma, Synovial 1Sarcoma 1

Interventions

entrectinib 2venetoclax 1trametinib 1tazemetostat 1sodium thiosulfate 1selpercatinib 1ripretinib 1repotrectinib 1pirtobrutinib 1pembrolizumab 1nirogacestat 1larotrectinib 1dabrafenib 1avapritinib 1atezolizumab 1Taxes 1Specimen Handling 1Rituximab 1Restraint, Physical 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × tazemetostat × Sarcoma × Clear all
NCT02601950 2025-06-22

A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Ipsen

Phase 2 Completed
267 enrolled 25 charts 1 FDA
Sarcoma

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡